Perfil
Richard Schoenfeld is Vice President of Operations for PharmAthene, Inc. He joined PharmAthene in October 2005.
He was Vice President of Supply Chain Management for EMD Pharmaceuticals and Senior Vice President of Engineering and Technology Development for Genzyme.
Mr. Schoenfeld held various positions at Endotronics and Monsanto.
He had 30 years of experience in developing and manufacturing proteins.
Mr. Schoenfeld received an Advanced Graduate Certificate in Business Ethics from Bentley College.
He received an MS and a PhD in Bioengineering from the Polytechnic Institute of Brooklyn, a BS in Chemical Engineering from Northeastern University and an MBA from St. Louis University.
Antiguos cargos conocidos de Richard Schoenfeld.
| Empresas | Cargo | Fin |
|---|---|---|
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology Develops biotherapeutics to address biological pathogens and chemicals | Director de Operaciones | 09/08/2007 |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology Develops bio therapeutics to address biological pathogens and chemicals | Corporate Officer/Principal | - |
Formación de Richard Schoenfeld.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology Develops biotherapeutics to address biological pathogens and chemicals | Health Technology |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Polytechnic University
Polytechnic University Other Consumer ServicesConsumer Services College/University | Consumer Services |
St. Louis University
St. Louis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology Develops bio therapeutics to address biological pathogens and chemicals | Health Technology |
- Bolsa de valores
- Insiders
- Richard Schoenfeld
















